General
All chemicals were reagent grade and used as purchased. All of the reactions except ester hydrolysis were performed under an argon atmosphere. Reactions were monitored by TLC using Merck TLC silica gel 60 F-254 aluminium sheets.
Compounds were visualized by UV light (254 and 366 nm) or by staining with a solution of ninhydrin in ethanol. Column chromatography was carried out on silica gel 60 (0.04-0.063 mm).
Melting points were recorded on a Kofler system. 
Synthesis of the tris(2-aminobenzimidazole) derivative 7 Bis-[2-(tert-butoxycarbonylamino)ethyl]-(2-aminoethyl)amine (2).
In a similar manner as described in [1] , a solution of tris(2-aminoethyl)amine 1 (1.42 mL, 9.52 mmol) in 50 mL of THF (abs.) was cooled to 0° C. A solution of Boc-ON (4.95 g, 20.1 mmol) in 50 mL of THF (abs.) was added dropwise during 2.5 h. The yellow solution was stirred for 46 h at rt. After removal of the solvent under reduced pressure, the remaining oil was dissolved in 50 mL of ethyl acetate and washed twice with 0.5 M NaOH. The combined aqueous phases were diluted with brine and S2 reextracted with ethyl acetate thrice. The combined organic phases were dried over 347.26528.
4-Amino-3-(3-{2-[bis-(2-{tert-butoxycarbonylamino}ethyl)amino]ethyl}thio-ureido)benzoic acid methyl ester (3).
In a similar manner as described in [1] 2, 165.9, 155.6, 149.2, 130.3, 128.9, 122.0, 116.3, 114.4, 77.5, 53.5, 52.3, 51.3, 42.1, 38.2, 28 
2-(2-{Bis-[2-(1H-benzimidazol-2-ylamino)ethyl]amino}ethylamino)-1H-benzimidazole-5-carboxylic acid (8).
This compound was prepared in a similar manner as described in [1] : 239 mg (0.21 mmol) of the TFA-salt of 7 were converted to the HClsalt using DOWEX ion exchange resin (Cl − -form). This was then dissolved in 7.5 mL 
6-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}hexanoic acid (9)
.
Synthesis of PNA conjugates
Synthesis of PNA 10mers (The method described here closely resembles a method we published earlier [3] for the synthesis of tripeptides unrelated to PNA). PNA 10mers were assembled manually on a solid support (Rink Amide MBHA resin purchased from Novabiochem, now incorporated into Merck Millipore, Darmstadt, Germany) by using 2 mL polyethylene syringe reactors that were equipped with a fritted disc. Peptide nucleic acid monomers were purchased from Link Technologies (Bellshill, UK). Fmoc-α N-Lys( ε N-Boc)OH, HOBt and DIC were from Sigma-Aldrich.
The 10mers were synthesized using the following procedure: After swelling the resin (100 mg) with DCM for 1.5 h, the solvent was substituted by NMP. To release the amine the Fmoc-protected resin was treated with piperidine (20% in DMF) three times (15 min, 10 min, 5 min). Thereafter, the resin was washed with NMP 5 times.
For coupling, the Fmoc-amino acid or the Fmoc-PNA monomer (3 equiv) was dissolved in 1 mL of NMP together with HOBt (3 equiv) and DIC (3 equiv). After shaking for 5 min it was added to the resin. The mixture was shaken at rt until the Kaiser test showed complete coupling. The resin was repeatedly washed with NMP and the Fmoc group was removed as described before. After washing with NMP for 5 times, subsequent Fmoc-protected monomer was attached using the same procedure as before. 
Cleavage and aggregation studies
For experimental details see [1] . 19.11.2014 16:22:15 
